- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT07629284
Home-Based Tele-Rehabilitation for Respiratory Function in Children With Duchenne Muscular Dystrophy
1 juni 2026 uppdaterad av: Jeong Yi Kwon, Samsung Medical Center
Feasibility and Preliminary Clinical Effects of a Home-Based, Remotely Delivered Respiratory Rehabilitation Program for Children With Duchenne Muscular Dystrophy
This study evaluates the feasibility and preliminary clinical effects of a home-based tele-rehabilitation program aimed at improving respiratory function in children with Duchenne Muscular Dystrophy (DMD).
Studieöversikt
Status
Anmälan via inbjudan
Betingelser
Intervention / Behandling
Detaljerad beskrivning
This is a prospective single-arm interventional study evaluating a 6-week home-based tele-rehabilitation program for respiratory function in children with Duchenne Muscular Dystrophy.
The intervention includes weekly remote education sessions and home-based exercises, with assessments conducted before and after the intervention and a 2-week follow-up for adherence monitoring.
Studietyp
Interventionell
Inskrivning (Beräknad)
12
Fas
- Inte tillämpbar
Kontakter och platser
Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.
Studieorter
-
-
Seoul
-
Seoul, Seoul, Sydkorea, 06351
- Samsung Medical Center
-
-
Deltagandekriterier
Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.
Urvalskriterier
Åldrar som är berättigade till studier
- Barn
- Vuxen
- Äldre vuxen
Tar emot friska volontärer
Nej
Beskrivning
Inclusion Criteria:
- Children aged 3 years or older with genetically confirmed Duchenne muscular dystrophy
- Participants who are able to understand the study procedures and appropriately participate in the study
Exclusion Criteria:
- Requirement for daytime ventilator support or invasive mechanical ventilation via tracheostomy (nighttime non-invasive ventilation such as positive airway pressure ventilation is allowed)
- History of peripheral nerve injury
- History of major surgery within 12 weeks prior to enrollment or expected major surgery during the study period
- History of central nervous system disorders (e.g., cerebral infarction or spinal cord injury)
- Severe cognitive impairment or other conditions that may interfere with participation in the study procedures
Studieplan
Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: N/A
- Interventionsmodell: Enskild gruppuppgift
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Home-Based Telerehabilitation Group
Participants with Duchenne muscular dystrophy will receive a 6-week home-based telerehabilitation respiratory program including weekly remote education sessions, caregiver-assisted respiratory exercises, self-directed home exercises, and exercise log monitoring.
Outcomes will be assessed at pre-intervention, post-intervention, and 2-week follow-up.
|
A 6-week caregiver-assisted home-based respiratory telerehabilitation program for children with Duchenne muscular dystrophy.
The program includes weekly remote education sessions, respiratory muscle exercises, airway clearance training, relaxation positioning, and self-directed home exercises performed at least 5 times per week.
Outcomes are assessed before and after the intervention and at 2-week follow-up.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Feasibility of the Home-Based Respiratory Tele-rehabilitation Program
Tidsram: Baseline to immediately after the 6-week intervention
|
Feasibility of the home-based respiratory telerehabilitation program will be assessed using exercise adherence rate, session attendance rate, and exercise log completion during the 6-week intervention period.
These measures will be summarized descriptively as indicators of program feasibility.
Higher percentages indicate better feasibility.
|
Baseline to immediately after the 6-week intervention
|
|
Acceptability of the Home-Based Respiratory Tele-rehabilitation Program
Tidsram: Immediately after the 6-week intervention and at 2-week follow-up
|
Acceptability of the home-based respiratory telerehabilitation program will be assessed using caregiver-reported satisfaction, perceived exercise difficulty, caregiver burden, and child participation questionnaires during the intervention period.
Higher satisfaction and participation scores indicate greater acceptability, whereas higher perceived difficulty and caregiver burden scores indicate lower acceptability.
|
Immediately after the 6-week intervention and at 2-week follow-up
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Inspiratory Muscle Strength
Tidsram: Baseline and immediately after the 6-week intervention
|
Inspiratory muscle strength will be assessed using maximal inspiratory pressure (MIP).
Measurements will be recorded in centimeters of water pressure (cmH2O).
Higher values indicate greater inspiratory muscle strength.
|
Baseline and immediately after the 6-week intervention
|
|
Expiratory Muscle Strength
Tidsram: Baseline and immediately after the 6-week intervention
|
Expiratory muscle strength will be assessed using maximal expiratory pressure (MEP).
Measurements will be recorded in centimeters of water pressure (cmH2O).
Higher values indicate greater expiratory muscle strength.
|
Baseline and immediately after the 6-week intervention
|
|
Respiratory Muscle Function
Tidsram: Baseline and immediately after the 6-week intervention
|
Respiratory muscle function will be assessed using inspiratory muscle endurance time, surface electromyography (sEMG) of the sternocleidomastoid muscle, and respiratory muscle ultrasonography.
Inspiratory muscle endurance will be measured in seconds, and respiratory muscle thickness will be measured in millimeters (mm).
Higher endurance time and greater muscle thickness indicate improved respiratory muscle function.
|
Baseline and immediately after the 6-week intervention
|
|
Physical Functional Performance
Tidsram: Baseline and immediately after the 6-week intervention
|
Physical functional performance will be assessed using the Vignos Scale, Brooke Upper Extremity Functional Rating Scale, and North Star Ambulatory Assessment (NSAA).
The Vignos Scale ranges from 1 to 10, with higher scores indicating greater lower extremity disability.
The Brooke Scale ranges from 1 to 6, with higher scores indicating greater upper extremity functional limitation.
The NSAA ranges from 0 to 34, with higher scores indicating better motor function.
|
Baseline and immediately after the 6-week intervention
|
|
Functional Exercise Capacity
Tidsram: Baseline and immediately after the 6-week intervention
|
Functional exercise capacity will be assessed using the 6-Minute Walk Test (6MWT).
Total walking distance will be recorded in meters.
Greater walking distance indicates better functional exercise capacity.
|
Baseline and immediately after the 6-week intervention
|
Samarbetspartners och utredare
Det är här du hittar personer och organisationer som är involverade i denna studie.
Sponsor
Studieavstämningsdatum
Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.
Studera stora datum
Studiestart (Faktisk)
23 januari 2026
Primärt slutförande (Beräknad)
28 februari 2027
Avslutad studie (Beräknad)
31 mars 2027
Studieregistreringsdatum
Först inskickad
20 maj 2026
Först inskickad som uppfyllde QC-kriterierna
1 juni 2026
Första postat (Faktisk)
5 juni 2026
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
5 juni 2026
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
1 juni 2026
Senast verifierad
1 juni 2026
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 2025-12-123
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
OBESLUTSAM
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Nej
Studerar en amerikansk FDA-reglerad produktprodukt
Nej
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .